Abstract
Nifedipine is a new antianginal drug, the calcium-antagonistic inhibitory action on excitation-contraction coupling apparently being so pronounced that, in therapeutic dosage, all other pharmacological properties are negligible. Its effect on exercise tolerance in angina was assessed by an exercise study involving 14 patients: single-stage exercise tests were chosen and the advantages of this are given. Our results suggest that the onset of action occurs after about 20 minutes, reaches a peak of activity at approximately one-half to two hours, and some effect may still be present at three hours. There was a significant improvement in exercise times with a mean rise of 50 per cent over placebo.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Birkett D. A., Chamberlain D. A. Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment. Br Med J. 1966 Aug 27;2(5512):500–502. doi: 10.1136/bmj.2.5512.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CHRISTENSSON B., KARLEFORS T., WESTLING H. HAEMODYNAMIC EFFECTS OF NITROGLYCERIN IN PATIENTS WITH CORONARY HEART DISEASE. Br Heart J. 1965 Jul;27:511–519. doi: 10.1136/hrt.27.4.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coltart D. J. Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris. Br Heart J. 1971 Jan;33(1):62–64. doi: 10.1136/hrt.33.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dagenais G. R., Mason R. E., Friesinger G. C., Wender C., Ross R. S. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate. Johns Hopkins Med J. 1969 Dec;125(6):301–311. [PubMed] [Google Scholar]
- Fleckenstein A., Tritthart H., Döring H. J., Byon K. Y. BAY a 1040--ein hochaktiver Ca -antagonistischer Inhibitor der elektro-mechanischen Koppelungsprozesse im Warmblüter-Myokard. Arzneimittelforschung. 1972 Jan;22(1):22–33. [PubMed] [Google Scholar]
- Goldstein R. E., Rosing D. R., Redwood D. R., Beiser G. D., Epstein S. E. Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Circulation. 1971 May;43(5):629–640. doi: 10.1161/01.cir.43.5.629. [DOI] [PubMed] [Google Scholar]
- Grün G., Fleckenstein A. Die elektromechanische Entkoppelung der glatten Gefässmuskulatur als Grundprinzip der Coronardilatation durch 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäure-dimethylester (BAY a 1040, Nifedipine. Arzneimittelforschung. 1972 Feb;22(2):334–344. [PubMed] [Google Scholar]
- Redwood D. R., Rosing D. R., Goldstein R. E., Beiser G. D., Epstein S. E. Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation. 1971 May;43(5):618–628. doi: 10.1161/01.cir.43.5.618. [DOI] [PubMed] [Google Scholar]
- Robinson B. F. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation. 1967 Jun;35(6):1073–1083. doi: 10.1161/01.cir.35.6.1073. [DOI] [PubMed] [Google Scholar]
- Vater W., Kroneberg G., Hoffmeister F., Saller H., Meng K., Oberdorf A., Puls W., Schlossmann K., Stoepel K. Zur Pharmakologie von 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester (Nifedipine), BAY a 1040. Arzneimittelforschung. 1972 Jan;22(1):1–14. [PubMed] [Google Scholar]
- Wilson A. G., Brooke O. G., Lloyd H. J., Robinson B. F. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol. Br Med J. 1969 Nov 15;4(5680):399–401. doi: 10.1136/bmj.4.5680.399. [DOI] [PMC free article] [PubMed] [Google Scholar]